-
1
-
-
0024247485
-
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma
-
Brodeur, G. M.; Seeger, R. C.; Barrett, A.; Castleberry, R. P.; D'Angio, G.; de Bernardi; Bernardi, B. D.; Evans, A. E.; Favrot, M.; Freeman, A. I. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J. Clin. Oncol. 1998, 6, 1874-1881.
-
(1998)
J. Clin. Oncol
, vol.6
, pp. 1874-1881
-
-
Brodeur, G.M.1
Seeger, R.C.2
Barrett, A.3
Castleberry, R.P.4
D'Angio, G.5
de Bernardi6
Bernardi, B.D.7
Evans, A.E.8
Favrot, M.9
Freeman, A.I.10
-
2
-
-
77953523121
-
Recent advances in neuroblastoma
-
Maris, J. M.; Maris, J. M. Recent advances in neuroblastoma. N. Engl. J. Med. 2010, 362 (23), 2202-2211.
-
(2010)
N. Engl. J. Med
, vol.362
, Issue.23
, pp. 2202-2211
-
-
Maris, J.M.1
Maris, J.M.2
-
3
-
-
0034672187
-
Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs
-
Lovat, P. E.; Ranalli, M.; Bernassola, F.; Tilby, M.; Malcolm, A. J.; Pearson, A. D.; Piacentini, M.; Melino, G.; Redfern, C. P. Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs. Int. J. Cancer 2000, 88 (6), 977-985.
-
(2000)
Int. J. Cancer
, vol.88
, Issue.6
, pp. 977-985
-
-
Lovat, P.E.1
Ranalli, M.2
Bernassola, F.3
Tilby, M.4
Malcolm, A.J.5
Pearson, A.D.6
Piacentini, M.7
Melino, G.8
Redfern, C.P.9
-
4
-
-
36049033401
-
Neuroblastoma
-
Ishola, T. A.; Chung, D. H. Neuroblastoma. Surg. Oncol. 2007, 16 (3), 149-156.
-
(2007)
Surg. Oncol
, vol.16
, Issue.3
, pp. 149-156
-
-
Ishola, T.A.1
Chung, D.H.2
-
5
-
-
0036897019
-
Selective retinoids and rexinoids in cancer therapy and chemoprevention
-
Zusi, F. C.; Lorenzi, M. V.; Vivat-Hannah, V. Selective retinoids and rexinoids in cancer therapy and chemoprevention. Drug Discov. Today 2002, 7 (23), 1165-1174.
-
(2002)
Drug Discov. Today
, vol.7
, Issue.23
, pp. 1165-1174
-
-
Zusi, F.C.1
Lorenzi, M.V.2
Vivat-Hannah, V.3
-
6
-
-
14644418461
-
Nonclassical retinoids and lung carcinogenesis
-
Dragnev, K. H.; Petty, W. J.; Ma, Y.; Rigas, J. R.; Dmitrovsky, E.; Nonclassical retinoids and lung carcinogenesis. Clin. Lung Cancer 2005, 6 (4), 237-244.
-
(2005)
Clin. Lung Cancer
, vol.6
, Issue.4
, pp. 237-244
-
-
Dragnev, K.H.1
Petty, W.J.2
Ma, Y.3
Rigas, J.R.4
Dmitrovsky, E.5
-
7
-
-
12844273744
-
Emerging role of rexinoids in non-small cell lung cancer: Focus on bexarotene
-
Rigas, J. R.; Dragnev, K. H.; Rigas, J. R.; Dragnev, K. H. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene. Oncologist 2005, 10 (1), 22-33.
-
(2005)
Oncologist
, vol.10
, Issue.1
, pp. 22-33
-
-
Rigas, J.R.1
Dragnev, K.H.2
Rigas, J.R.3
Dragnev, K.H.4
-
8
-
-
61449106633
-
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children's oncology group study
-
Matthay, K. K.; Reynolds, C. P.; Seeger, R. C.; Shimada, H.; Adkins, E. S.; Haas-Kogan, D.; Gerbing, R. B.; London, W. B.; Villablanca, J. G. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J. Clin. Oncol. 2009, 27 (7), 1007-1013.
-
(2009)
J. Clin. Oncol
, vol.27
, Issue.7
, pp. 1007-1013
-
-
Matthay, K.K.1
Reynolds, C.P.2
Seeger, R.C.3
Shimada, H.4
Adkins, E.S.5
Haas-Kogan, D.6
Gerbing, R.B.7
London, W.B.8
Villablanca, J.G.9
-
9
-
-
0036094845
-
Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069
-
Wu, K.; Kim, H.-T.; Rodriquez, J. L.; Hilsenbeck, S. G.; Mohsin, S. K.; Xu, X.-C.; Lamph, W. W.; Kuhn, J. G.; Green, J. E.; Brown, P. H. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069. Cancer Epidemiol. Biomarkers Prev. 2002, 11 (5), 467-474.
-
(2002)
Cancer Epidemiol. Biomarkers Prev
, vol.11
, Issue.5
, pp. 467-474
-
-
Wu, K.1
Kim, H.-T.2
Rodriquez, J.L.3
Hilsenbeck, S.G.4
Mohsin, S.K.5
Xu, X.-C.6
Lamph, W.W.7
Kuhn, J.G.8
Green, J.E.9
Brown, P.H.10
-
10
-
-
0037112520
-
The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice
-
Wu, K.; Zhang, Y.; Xu, X.-C.; Hill, J.; Celestino, J.; Kim, H.-T.; Mohsin, S. K.; Hilsenbeck, S. G.; Lamph, W. W.; Bissonette, R.; Brown, P. H. The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice. Cancer Res. 2002, 62 (22), 6376-6380.
-
(2002)
Cancer Res
, vol.62
, Issue.22
, pp. 6376-6380
-
-
Wu, K.1
Zhang, Y.2
Xu, X.-C.3
Hill, J.4
Celestino, J.5
Kim, H.-T.6
Mohsin, S.K.7
Hilsenbeck, S.G.8
Lamph, W.W.9
Bissonette, R.10
Brown, P.H.11
-
11
-
-
48949099555
-
N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells
-
Das, A.; Banik, N. L.; Ray, S. K. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells. Brain Res. 2008, 1227, 207-215.
-
(2008)
Brain Res
, vol.1227
, pp. 207-215
-
-
Das, A.1
Banik, N.L.2
Ray, S.K.3
-
12
-
-
34047240758
-
All-trans-retinoic acid and 13-cisretinoic acid: Pharmacokinetics and biological activity in different cell culture models of human keratinocytes
-
Schroeder, M.; Zouboulis, C. C. All-trans-retinoic acid and 13-cisretinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes. Horm. Metab. Res. 2007, 39 (2), 136-140.
-
(2007)
Horm. Metab. Res
, vol.39
, Issue.2
, pp. 136-140
-
-
Schroeder, M.1
Zouboulis, C.C.2
-
13
-
-
0029005362
-
Gene expression and neuroblastoma cell differentiation in response to retinoic acid: Differential effects of 9-cis and all-trans retinoic acid
-
Redfern, C. P.; Lovat, P. E.; Malcolm, A. J.; Pearson, A. D. Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. Eur. J. Cancer 1995, 31A (4), 486-494.
-
(1995)
Eur. J. Cancer
, vol.31 A
, Issue.4
, pp. 486-494
-
-
Redfern, C.P.1
Lovat, P.E.2
Malcolm, A.J.3
Pearson, A.D.4
-
14
-
-
21244450000
-
The NF kappaB pathway mediates fenretinide-induced apoptosis in SHSY5Y neuroblastoma cells
-
Hewson, Q. D.; Lovat, P. E.; Corazzari, M.; Catterall, J. B.; Redfern, C. P.; Hewson, Q. D. C.; Redfern, C. P. F. The NF kappaB pathway mediates fenretinide-induced apoptosis in SHSY5Y neuroblastoma cells. Apoptosis. 2005, 10 (3), 493-498.
-
(2005)
Apoptosis
, vol.10
, Issue.3
, pp. 493-498
-
-
Hewson, Q.D.1
Lovat, P.E.2
Corazzari, M.3
Catterall, J.B.4
Redfern, C.P.5
Hewson, Q.D.C.6
Redfern, C.P.F.7
-
15
-
-
23944510163
-
The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma
-
Lovat, P. E.; Corazzari, M.; Di Sano, F.; Piacentini, M.; Redfern, C. P.; Lovat, P. E.; Corazzari, M.; Di Sano, F.; Piacentini, M.; Redfern, C. P. F. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma. Cancer Lett. 2005, 228 (1-2), 105-110.
-
(2005)
Cancer Lett
, vol.228
, Issue.1-2
, pp. 105-110
-
-
Lovat, P.E.1
Corazzari, M.2
Di Sano, F.3
Piacentini, M.4
Redfern, C.P.5
Lovat, P.E.6
Corazzari, M.7
Di Sano, F.8
Piacentini, M.9
Redfern, C.P.F.10
-
16
-
-
79952572899
-
ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cells
-
Yang, H.; Nie, Y.; Li, Y.; Wan, Y. J.; Yang, H.; Nie, Y.; Li, Y.; Wan, Y.-J. Y. ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cells. Biochem. Pharmacol. 2011, 81 (7), 910-916.
-
(2011)
Biochem. Pharmacol
, vol.81
, Issue.7
, pp. 910-916
-
-
Yang, H.1
Nie, Y.2
Li, Y.3
Wan, Y.J.4
Yang, H.5
Nie, Y.6
Li, Y.7
Wan Y.-J., Y.8
-
17
-
-
0037445123
-
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer
-
Esteva, F. J.; Glaspy, J.; Baidas, S.; Laufman, L.; Hutchins, L.; Dickler, M.; Tripathy, D.; Cohen, R.; de Michele, A.; Yocum, R. C.; Osborne, C. K.; Hayes, D. F.; Hortobagyi, G. N.; Winer, E.; Demetri, G. D. Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer. J. Clin. Oncol. 2003, 21 (6), 999-1006.
-
(2003)
J. Clin. Oncol
, vol.21
, Issue.6
, pp. 999-1006
-
-
Esteva, F.J.1
Glaspy, J.2
Baidas, S.3
Laufman, L.4
Hutchins, L.5
Dickler, M.6
Tripathy, D.7
Cohen, R.8
de Michele, A.9
Yocum, R.C.10
Osborne, C.K.11
Hayes, D.F.12
Hortobagyi, G.N.13
Winer, E.14
Demetri, G.D.15
-
18
-
-
0033554684
-
Treatment of highrisk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
-
Children's Cancer Group
-
Matthay, K. K.; Villablanca, J. G.; Seeger, R. C.; Stram, D. O.; Harris, R. E.; Ramsay, N. K.; Swift, P.; Shimada, H.; Black, C. T.; Brodeur, G. M.; Gerbing, R. B.; Reynolds, C. P. Treatment of highrisk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N. Engl. J. Med. 1999, 341 (16), 1165-1173.
-
(1999)
N. Engl. J. Med
, vol.341
, Issue.16
, pp. 1165-1173
-
-
Matthay, K.K.1
Villablanca, J.G.2
Seeger, R.C.3
Stram, D.O.4
Harris, R.E.5
Ramsay, N.K.6
Swift, P.7
Shimada, H.8
Black, C.T.9
Brodeur, G.M.10
Gerbing, R.B.11
Reynolds, C.P.12
-
19
-
-
0037420022
-
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: Results from a randomized placebo-controlled trial
-
Kurie, J. M.; Lotan, R.; Lee, J. J.; Lee, J. S.; Morice, R. C.; Liu, D. D.; Xu, X.-C.; Khuri, F. R.; Ro, J. Y.; Hittelman, W. N.; Walsh, G. L.; Roth, J. A.; Minna, J. D.; Hong, W. K. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J. Natl. Cancer Inst. 2003, 95 (3), 206-214.
-
(2003)
J. Natl. Cancer Inst
, vol.95
, Issue.3
, pp. 206-214
-
-
Kurie, J.M.1
Lotan, R.2
Lee, J.J.3
Lee, J.S.4
Morice, R.C.5
Liu, D.D.6
Xu, X.-C.7
Khuri, F.R.8
Ro, J.Y.9
Hittelman, W.N.10
Walsh, G.L.11
Roth, J.A.12
Minna, J.D.13
Hong, W.K.14
-
20
-
-
0034999546
-
Worldwide Bexarotene Study, G. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma
-
Duvic, M.; Martin, A. G.; Kim, Y.; Olsen, E.; Wood, G. S.; Crowley, C. A.; Yocum, R. C.; Worldwide Bexarotene Study, G. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch. Dermatol. 2001, 137 (5), 581-593.
-
(2001)
Arch. Dermatol
, vol.137
, Issue.5
, pp. 581-593
-
-
Duvic, M.1
Martin, A.G.2
Kim, Y.3
Olsen, E.4
Wood, G.S.5
Crowley, C.A.6
Yocum, R.C.7
-
21
-
-
0033520713
-
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
-
Veronesi, U.; de Palo, G.; Marubini, E.; Costa, A.; Formelli, F.; Mariani, L.; Decensi, A.; Camerini, T.; del Turco, M. R.; di Mauro, M. G.; Muraca, M. G.; del Vecchio, M.; Pinto, C.; D'Aiuto, G.; Boni, C.; Campa, T.; Magni, A.; Miceli, R.; Perloff, M.; Malone, W. F.; Sporn, M. B. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J. Natl. Cancer Inst. 1999, 91 (21), 1847-1856.
-
(1999)
J. Natl. Cancer Inst
, vol.91
, Issue.21
, pp. 1847-1856
-
-
Veronesi, U.1
de Palo, G.2
Marubini, E.3
Costa, A.4
Formelli, F.5
Mariani, L.6
Decensi, A.7
Camerini, T.8
Del Turco, M.R.9
Di Mauro, M.G.10
Muraca, M.G.11
del Vecchio, M.12
Pinto, C.13
D'Aiuto, G.14
Boni, C.15
Campa, T.16
Magni, A.17
Miceli, R.18
Perloff, M.19
Malone, W.F.20
Sporn, M.B.21
more..
-
22
-
-
33646010000
-
Clinical trials with retinoids for breast cancer chemoprevention
-
Zanardi, S.; Serrano, D.; Argusti, A.; Barile, M.; Puntoni, M.; Decensi, A. Clinical trials with retinoids for breast cancer chemoprevention. Endocr. Relat. Cancer 2006, 13 (1), 51-68.
-
(2006)
Endocr. Relat. Cancer
, vol.13
, Issue.1
, pp. 51-68
-
-
Zanardi, S.1
Serrano, D.2
Argusti, A.3
Barile, M.4
Puntoni, M.5
Decensi, A.6
-
23
-
-
79551713864
-
Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients
-
Lee, J. J.; Wu, X.; Hildebrandt, M. A.; Yang, H.; Khuri, F. R.; Kim, E.; Gu, J.; Ye, Y.; Lotan, R.; Spitz, M. R.; Hong, W. K.; Lee, J. J.; Wu, X.; Hildebrandt, M. A. T.; Yang, H.; Khuri, F. R.; Kim, E.; Gu, J.; Ye, Y.; Lotan, R.; Spitz, M. R.; Hong, W. K. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev. Res. 2011, 4 (2), 185-193.
-
(2011)
Cancer Prev. Res
, vol.4
, Issue.2
, pp. 185-193
-
-
Lee, J.J.1
Wu, X.2
Hildebrandt, M.A.3
Yang, H.4
Khuri, F.R.5
Kim, E.6
Gu, J.7
Ye, Y.8
Lotan, R.9
Spitz, M.R.10
Hong, W.K.11
Lee, J.J.12
Wu, X.13
Hildebrandt, M.A.T.14
Yang, H.15
Khuri, F.R.16
Kim, E.17
Gu, J.18
Ye, Y.19
Lotan, R.20
Spitz, M.R.21
Hong, W.K.22
more..
-
24
-
-
0023631093
-
All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia. Report of 6 cases
-
Huang, M. E.; Ye, Y. C.; Chen, S. R.; Zhao, J. C.; Gu, L. J.; Cai, J. R.; Zhao, L.; Xie, J. X.; Shen, Z. X.; Wang, Z. Y. All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia. Report of 6 cases. Chin. Med. J. 1987, 100 (12), 949-953.
-
(1987)
Chin. Med. J
, vol.100
, Issue.12
, pp. 949-953
-
-
Huang, M.E.1
Ye, Y.C.2
Chen, S.R.3
Zhao, J.C.4
Gu, L.J.5
Cai, J.R.6
Zhao, L.7
Xie, J.X.8
Shen, Z.X.9
Wang, Z.Y.10
-
25
-
-
0026647140
-
The retinoic acid syndrome in acute promyelocytic leukemia
-
Frankel, S. R.; Eardley, A.; Lauwers, G.; Weiss, M.; Warrell, R. P., Jr. The retinoic acid syndrome in acute promyelocytic leukemia. Ann. Intern. Med. 1992, 117 (4), 292-296.
-
(1992)
Ann. Intern. Med
, vol.117
, Issue.4
, pp. 292-296
-
-
Frankel, S.R.1
Eardley, A.2
Lauwers, G.3
Weiss, M.4
Warrell Jr., R.P.5
-
26
-
-
0027104448
-
All-trans-retinoic acid: What is it good for?
-
Warrell, R. P., Jr. All-trans-retinoic acid: what is it good for? J. Clin. Oncol. 1992, 10 (11), 1659-1661.
-
(1992)
J. Clin. Oncol
, vol.10
, Issue.11
, pp. 1659-1661
-
-
Warrell Jr., R.P.1
-
27
-
-
0027173862
-
Acute promyelocytic leukemia
-
Warrell, R. P., Jr.; de The, H.; Wang, Z. Y.; Degos, L. Acute promyelocytic leukemia. N. Engl. J. Med. 1993, 329 (3), 177-189.
-
(1993)
N. Engl. J. Med
, vol.329
, Issue.3
, pp. 177-189
-
-
Warrell Jr., R.P.1
de The, H.2
Wang, Z.Y.3
Degos, L.4
-
28
-
-
27944508740
-
Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance
-
Ren, M.; Pozzi, S.; Bistulfi, G.; Somenzi, G.; Rossetti, S.; Sacchi, N. Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance. Mol. Cell Biol. 2005, 25 (23), 10591-10603.
-
(2005)
Mol. Cell Biol
, vol.25
, Issue.23
, pp. 10591-10603
-
-
Ren, M.1
Pozzi, S.2
Bistulfi, G.3
Somenzi, G.4
Rossetti, S.5
Sacchi, N.6
-
29
-
-
0028305671
-
Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues
-
Xu, X. C.; Ro, J. Y.; Lee, J. S.; Shin, D. M.; Hong, W. K.; Lotan, R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res. 1994, 54 (13), 3580-3587.
-
(1994)
Cancer Res
, vol.54
, Issue.13
, pp. 3580-3587
-
-
Xu, X.C.1
Ro, J.Y.2
Lee, J.S.3
Shin, D.M.4
Hong, W.K.5
Lotan, R.6
-
30
-
-
0029044431
-
Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin
-
Lotan, R.; Xu, X. C.; Lippman, S. M.; Ro, J. Y.; Lee, J. S.; Lee, J. J.; Hong, W. K. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N. Engl. J. Med. 1995, 332 (21), 1405-1410.
-
(1995)
N. Engl. J. Med
, vol.332
, Issue.21
, pp. 1405-1410
-
-
Lotan, R.1
Xu, X.C.2
Lippman, S.M.3
Ro, J.Y.4
Lee, J.S.5
Lee, J.J.6
Hong, W.K.7
-
31
-
-
0030828338
-
Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
-
Widschwendter, M.; Berger, J.; Daxenbichler, G.; Muller-Holzner, E.; Widschwendter, A.; Mayr, A.; Marth, C.; Zeimet, A. G. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res. 1997, 57 (19), 4158-4161.
-
(1997)
Cancer Res
, vol.57
, Issue.19
, pp. 4158-4161
-
-
Widschwendter, M.1
Berger, J.2
Daxenbichler, G.3
Muller-Holzner, E.4
Widschwendter, A.5
Mayr, A.6
Marth, C.7
Zeimet, A.G.8
-
32
-
-
15644381775
-
Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis
-
Xu, X. C.; Sneige, N.; Liu, X.; Nandagiri, R.; Lee, J. J.; Lukmanji, F.; Hortobagyi, G.; Lippman, S. M.; Dhingra, K.; Lotan, R. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res. 1997, 57 (22), 4992-4996.
-
(1997)
Cancer Res
, vol.57
, Issue.22
, pp. 4992-4996
-
-
Xu, X.C.1
Sneige, N.2
Liu, X.3
Nandagiri, R.4
Lee, J.J.5
Lukmanji, F.6
Hortobagyi, G.7
Lippman, S.M.8
Dhingra, K.9
Lotan, R.10
-
33
-
-
0030997822
-
Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: Implications for lung cancer development
-
Xu, X. C.; Sozzi, G.; Lee, J. S.; Lee, J. J.; Pastorino, U.; Pilotti, S.; Kurie, J. M.; Hong, W. K.; Lotan, R. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J. Natl. Cancer Inst. 1997, 89 (9), 624-629.
-
(1997)
J. Natl. Cancer Inst
, vol.89
, Issue.9
, pp. 624-629
-
-
Xu, X.C.1
Sozzi, G.2
Lee, J.S.3
Lee, J.J.4
Pastorino, U.5
Pilotti, S.6
Kurie, J.M.7
Hong, W.K.8
Lotan, R.9
-
34
-
-
0033523269
-
Nuclear Retinoid Acid Receptor Beta In Bronchial Epithelium of Smokers Before and During Chemoprevention
-
Xu, X. C.; Lee, J. S.; Lee, J. J.; Morice, R. C.; Liu, X.; Lippman, S. M.; Hong, W. K.; Lotan, R. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J. Natl. Cancer Inst. 1999, 91 (15), 1317-1321.
-
(1999)
J. Natl. Cancer Inst
, vol.91
, Issue.15
, pp. 1317-1321
-
-
Xu, X.C.1
Lee, J.S.2
Lee, J.J.3
Morice, R.C.4
Liu, X.5
Lippman, S.M.6
Hong, W.K.7
Lotan, R.8
-
35
-
-
0032706665
-
Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis
-
Qiu, H.; Zhang, W.; El-Naggar, A. K.; Lippman, S. M.; Lin, P.; Lotan, R.; Xu, X. C. Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis. Am. J. Pathol. 1999, 155 (5), 1519-1523.
-
(1999)
Am. J. Pathol
, vol.155
, Issue.5
, pp. 1519-1523
-
-
Qiu, H.1
Zhang, W.2
El-Naggar, A.K.3
Lippman, S.M.4
Lin, P.5
Lotan, R.6
Xu, X.C.7
-
36
-
-
0033986007
-
Differential expression of nuclear retinoid receptors in normal and malignant prostates
-
Lotan, Y.; Xu, X. C.; Shalev, M.; Lotan, R.; Williams, R.; Wheeler, T. M.; Thompson, T. C.; Kadmon, D. Differential expression of nuclear retinoid receptors in normal and malignant prostates. J. Clin. Oncol. 2000, 18 (1), 116-121.
-
(2000)
J. Clin. Oncol
, vol.18
, Issue.1
, pp. 116-121
-
-
Lotan, Y.1
Xu, X.C.2
Shalev, M.3
Lotan, R.4
Williams, R.5
Wheeler, T.M.6
Thompson, T.C.7
Kadmon, D.8
-
37
-
-
0032514374
-
Favourable prognostic significance of high-level retinoic acid receptor beta expression in neuroblastoma mediated by effects on cell cycle regulation
-
Cheung, B.; Hocker, J. E.; Smith, S. A.; Norris, M. D.; Haber, M.; Marshall, G. M. Favourable prognostic significance of high-level retinoic acid receptor beta expression in neuroblastoma mediated by effects on cell cycle regulation. Oncogene 1998, 17 (6), 751-759.
-
(1998)
Oncogene
, vol.17
, Issue.6
, pp. 751-759
-
-
Cheung, B.1
Hocker, J.E.2
Smith, S.A.3
Norris, M.D.4
Haber, M.5
Marshall, G.M.6
-
38
-
-
0038457750
-
Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter
-
Cheung, B.; Yan, J.; Smith, S. A.; Nguyen, T.; Lee, M.; Kavallaris, M.; Norris, M. D.; Haber, M.; Marshall, G. M. Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter. Int. J. Cancer 2003, 105 (6), 856-867.
-
(2003)
Int. J. Cancer
, vol.105
, Issue.6
, pp. 856-867
-
-
Cheung, B.1
Yan, J.2
Smith, S.A.3
Nguyen, T.4
Lee, M.5
Kavallaris, M.6
Norris, M.D.7
Haber, M.8
Marshall, G.M.9
-
39
-
-
85047696309
-
Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells
-
Li, M.; Song, S.; Lippman, S. M.; Zhang, X.-k.; Liu, X.; Lotan, R.; Xu, X.-C. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene 2002, 21 (3), 411-418.
-
(2002)
Oncogene
, vol.21
, Issue.3
, pp. 411-418
-
-
Li, M.1
Song, S.2
Lippman, S.M.3
Zhang, X.-K.4
Liu, X.5
Lotan, R.6
Xu, X.-C.7
-
40
-
-
34948835093
-
Histone deacetylase inhibitors regulate retinoic acid receptor beta expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms
-
De los Santos, M.; Zambrano, A.; Sanchez-Pacheco, A.; Aranda, A. Histone deacetylase inhibitors regulate retinoic acid receptor beta expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms. Mol. Endocrinol 2007, 21 (10), 2416-2426.
-
(2007)
Mol. Endocrinol
, vol.21
, Issue.10
, pp. 2416-2426
-
-
de los Santos, M.1
Zambrano, A.2
Sanchez-Pacheco, A.3
Aranda, A.4
-
41
-
-
33745842534
-
The estrogen-responsive B box protein is a novel regulator of the retinoid signal
-
Cheung, B. B.; Bell, J.; Raif, A.; Bohlken, A.; Yan, J.; Roediger, B.; Poljak, A.; Smith, S.; Lee, M.; Thomas, W. D.; Kavallaris, M.; Norris, M.; Haber, M.; Liu, H. L.; Zajchowski, D.; Marshall, G. M. The estrogen-responsive B box protein is a novel regulator of the retinoid signal. J. Biol. Chem. 2006, 281 (26), 18246-18256.
-
(2006)
J. Biol. Chem
, vol.281
, Issue.26
, pp. 18246-18256
-
-
Cheung, B.B.1
Bell, J.2
Raif, A.3
Bohlken, A.4
Yan, J.5
Roediger, B.6
Poljak, A.7
Smith, S.8
Lee, M.9
Thomas, W.D.10
Kavallaris, M.11
Norris, M.12
Haber, M.13
Liu, H.L.14
Zajchowski, D.15
Marshall, G.M.16
-
42
-
-
61849097812
-
The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation
-
Raif, A.; Marshall, G. M.; Bell, J. L.; Koach, J.; Tan, O.; D'Andreti, C.; Thomas, W.; Sekyere, E.; Norris, M.; Haber, M.; Kavallaris, M.; Cheung, B. B. The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation. Cancer Lett. 2009, 277 (1), 82-90.
-
(2009)
Cancer Lett
, vol.277
, Issue.1
, pp. 82-90
-
-
Raif, A.1
Marshall, G.M.2
Bell, J.L.3
Koach, J.4
Tan, O.5
D'Andreti, C.6
Thomas, W.7
Sekyere, E.8
Norris, M.9
Haber, M.10
Kavallaris, M.11
Cheung, B.B.12
-
43
-
-
25144469506
-
The retinoid anticancer signal: Mechanisms of target gene regulation
-
Liu, T.; Bohlken, A.; Kuljaca, S.; Lee, M.; Nguyen, T.; Smith, S.; Cheung, B.; Norris, M. D.; Haber, M.; Holloway, A. J.; Bowtell, D. D. L.; Marshall, G. M. The retinoid anticancer signal: mechanisms of target gene regulation. Br. J. Cancer. 2005, 93 (3), 310-318.
-
(2005)
Br. J. Cancer
, vol.93
, Issue.3
, pp. 310-318
-
-
Liu, T.1
Bohlken, A.2
Kuljaca, S.3
Lee, M.4
Nguyen, T.5
Smith, S.6
Cheung, B.7
Norris, M.D.8
Haber, M.9
Holloway, A.J.10
Bowtell, D.D.L.11
Marshall, G.M.12
-
44
-
-
58149234183
-
ATP7A is a novel target of retinoic acid receptor beta 2 in neuroblastoma cells
-
Bohlken, A.; Cheung, B. B.; Bell, J. L.; Koach, J.; Smith, S.; Sekyere, E.; Thomas, W.; Norris, M.; Haber, M.; Lovejoy, D. B.; Richardson, D. R.; Marshall, G. M. ATP7A is a novel target of retinoic acid receptor beta 2 in neuroblastoma cells. Br. J. Cancer 2009, 100 (1), 96-105.
-
(2009)
Br. J. Cancer
, vol.100
, Issue.1
, pp. 96-105
-
-
Bohlken, A.1
Cheung, B.B.2
Bell, J.L.3
Koach, J.4
Smith, S.5
Sekyere, E.6
Thomas, W.7
Norris, M.8
Haber, M.9
Lovejoy, D.B.10
Richardson, D.R.11
Marshall, G.M.12
-
45
-
-
34447103789
-
Trafficking of the copper- AT Pases, ATP7A and ATP7B: Role in copper homeostasis
-
La Fontaine, S.; Mercer, J. F. B. Trafficking of the copper- AT Pases, ATP7A and ATP7B: role in copper homeostasis. Arch. Biochem. Biophys. 2007, 463 (2), 149-167.
-
(2007)
Arch. Biochem. Biophys
, vol.463
, Issue.2
, pp. 149-167
-
-
la Fontaine, S.1
Mercer, J.F.B.2
-
46
-
-
2442471606
-
Intracellular copper transport in mammals
-
Prohaska, J. R.; Gybina, A. A. Intracellular copper transport in mammals. J. Nutr. 2004, 134 (5), 1003-1006.
-
(2004)
J. Nutr
, vol.134
, Issue.5
, pp. 1003-1006
-
-
Prohaska, J.R.1
Gybina, A.A.2
-
47
-
-
0030844529
-
HCTR1: A human gene for copper uptake identified by complementation in yeast
-
Zhou, B.; Gitschier, J. HCTR1: a human gene for copper uptake identified by complementation in yeast. Proc. Natl. Acad. Sci. USA 1997, 94 (14), 7481-7486.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, Issue.14
, pp. 7481-7486
-
-
Zhou, B.1
Gitschier, J.2
-
48
-
-
0037477740
-
A delicate balance: Homeostatic control of copper uptake and distribution
-
Pena, M. M.; Lee, J.; Thiele, D. J. A delicate balance: homeostatic control of copper uptake and distribution. J. Nutr. 1999, 129 (7), 1251-1260.
-
(1999)
J. Nutr
, vol.129
, Issue.7
, pp. 1251-1260
-
-
Pena, M.M.1
Lee, J.2
Thiele, D.J.3
-
49
-
-
1242317649
-
The SLC31 (Ctr) copper transporter family
-
Petris, M. J. The SLC31 (Ctr) copper transporter family. Pflugers Arch. 2004, 447 (5), 752-755.
-
(2004)
Pflugers Arch
, vol.447
, Issue.5
, pp. 752-755
-
-
Petris, M.J.1
-
50
-
-
0032769447
-
Molecular genetics and pathophysiology of Menkes disease
-
Kodama, H.; Murata, Y. Molecular genetics and pathophysiology of Menkes disease. Pediatr. Int. 1999, 41 (4), 430-435.
-
(1999)
Pediatr. Int
, vol.41
, Issue.4
, pp. 430-435
-
-
Kodama, H.1
Murata, Y.2
-
51
-
-
34447092712
-
Biochemical basis of regulation of human copper-transporting ATPases
-
Lutsenko, S.; LeShane, E. S.; Shinde, U. Biochemical basis of regulation of human copper-transporting ATPases. Arch. Biochem. Biophys. 2007, 463 (2), 134-148.
-
(2007)
Arch. Biochem. Biophys
, vol.463
, Issue.2
, pp. 134-148
-
-
Lutsenko, S.1
Leshane, E.S.2
Shinde, U.3
-
52
-
-
0038241789
-
Hepatic copper metabolism: Insights from genetic disease
-
Tao, T. Y.; Gitlin, J. D.; Tao, T. Y.; Gitlin, J. D. Hepatic copper metabolism: insights from genetic disease. Hepatology 2003, 37 (6), 1241-1247.
-
(2003)
Hepatology
, vol.37
, Issue.6
, pp. 1241-1247
-
-
Tao, T.Y.1
Gitlin, J.D.2
Tao, T.Y.3
Gitlin, J.D.4
-
53
-
-
0035965241
-
Copper specifically regulates intracellular phosphorylation of the Wilson's disease protein, a human copper-transporting ATPase
-
Vanderwerf, S. M.; Cooper, M. J.; Stetsenko, I. V.; Lutsenko, S. Copper specifically regulates intracellular phosphorylation of the Wilson's disease protein, a human copper-transporting ATPase. J Biol Chem. 2001, 276 (39), 36289-36294.
-
(2001)
J Biol Chem
, vol.276
, Issue.39
, pp. 36289-36294
-
-
Vanderwerf, S.M.1
Cooper, M.J.2
Stetsenko, I.V.3
Lutsenko, S.4
-
54
-
-
47049088252
-
Cellular multitasking: The dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance
-
Lutsenko, S.; Gupta, A.; Burkhead, J. L.; Zuzel, V. Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance. Arch. Biochem. Biophys. 2008, 476 (1), 22-32.
-
(2008)
Arch. Biochem. Biophys
, vol.476
, Issue.1
, pp. 22-32
-
-
Lutsenko, S.1
Gupta, A.2
Burkhead, J.L.3
Zuzel, V.4
-
55
-
-
33645754710
-
Solution structure of the N-domain of Wilson disease protein: Distinct nucleotide-binding environment and effects of disease mutations
-
Dmitriev, O.; Tsivkovskii, R.; Abildgaard, F.; Morgan, C. T.; Markley, J. L.; Lutsenko, S. Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations. Proc. Natl. Acad. Sci. USA 2006, 103 (14), 5302-5307.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, Issue.14
, pp. 5302-5307
-
-
Dmitriev, O.1
Tsivkovskii, R.2
Abildgaard, F.3
Morgan, C.T.4
Markley, J.L.5
Lutsenko, S.6
-
56
-
-
33744964528
-
Structure of the ATP binding domain from the Archaeoglobus fulgidus Cu+-ATPase
-
Sazinsky, M. H.; Mandal, A. K.; Arguello, J. M.; Rosenzweig, A. C. Structure of the ATP binding domain from the Archaeoglobus fulgidus Cu+-ATPase. J. Biol. Chem. 2006, 281 (16), 11161-11166.
-
(2006)
J. Biol. Chem
, vol.281
, Issue.16
, pp. 11161-11166
-
-
Sazinsky, M.H.1
Mandal, A.K.2
Arguello, J.M.3
Rosenzweig, A.C.4
-
57
-
-
0030802648
-
The copper chaperone for superoxide dismutase
-
Culotta, V. C.; Klomp, L. W.; Strain, J.; Casareno, R. L.; Krems, B.; Gitlin, J. D. The copper chaperone for superoxide dismutase. J. Biol. Chem. 1997, 272 (38), 23469-23472.
-
(1997)
J. Biol. Chem
, vol.272
, Issue.38
, pp. 23469-23472
-
-
Culotta, V.C.1
Klomp, L.W.2
Strain, J.3
Casareno, R.L.4
Krems, B.5
Gitlin, J.D.6
-
58
-
-
0030913489
-
Localization of integral membrane peptidylglycine alphaamidating monooxygenase in neuroendocrine cells
-
Milgram, S. L.; Kho, S. T.; Martin, G. V.; Mains, R. E.; Eipper, B. A. Localization of integral membrane peptidylglycine alphaamidating monooxygenase in neuroendocrine cells. J. Cell Sci. 1997, 110 (Pt 6), 695-706.
-
(1997)
J. Cell Sci
, vol.110
, Issue.Pt 6
, pp. 695-706
-
-
Milgram, S.L.1
Kho, S.T.2
Martin, G.V.3
Mains, R.E.4
Eipper, B.A.5
-
59
-
-
79953179664
-
Clusterin (apolipoprotein J), a molecular chaperone that facilitates degradation of the copper-ATPases ATP7A and ATP7B
-
Materia, S.; Cater, M. A.; Klomp, L. W.; Mercer, J. F.; La Fontaine, S.; Materia, S.; Cater, M. A.; Klomp, L. W. J.; Mercer, J. F. B.; la Fontaine, S. Clusterin (apolipoprotein J), a molecular chaperone that facilitates degradation of the copper-ATPases ATP7A and ATP7B. J. Biol. Chem. 2011, 286 (12), 10073-10083.
-
(2011)
J. Biol. Chem
, vol.286
, Issue.12
, pp. 10073-10083
-
-
Materia, S.1
Cater, M.A.2
Klomp, L.W.3
Mercer, J.F.4
la Fontaine, S.5
Materia, S.6
Cater, M.A.7
Klomp, L.W.J.8
Mercer, J.F.B.9
la Fontaine, S.10
-
60
-
-
25844505522
-
A single PDZ domain protein interacts with the Menkes copper ATPase, ATP7A. A new protein implicated in copper homeostasis
-
Stephenson, S. E. M.; Dubach, D.; Lim, C. M.; Mercer, J. F. B.; la Fontaine, S. A single PDZ domain protein interacts with the Menkes copper ATPase, ATP7A. A new protein implicated in copper homeostasis. J. Biol. Chem. 2005, 280 (39), 33270-33279.
-
(2005)
J. Biol. Chem
, vol.280
, Issue.39
, pp. 33270-33279
-
-
Stephenson, S.E.M.1
Dubach, D.2
Lim, C.M.3
Mercer, J.F.B.4
la Fontaine, S.5
-
61
-
-
58649124072
-
Roles and mechanisms of copper transporting ATPases in cancer pathogenesis
-
Zhang, Y.; Li, M.; Yao, Q.; Chen, C. Roles and mechanisms of copper transporting ATPases in cancer pathogenesis. Med. Sci. Monit. 2009, 15 (1), RA1-RA5.
-
(2009)
Med. Sci. Monit
, vol.15
, Issue.1
, pp. 1-5
-
-
Zhang, Y.1
Li, M.2
Yao, Q.3
Chen, C.4
-
62
-
-
38449089214
-
Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines
-
Yoshizawa, K.; Nozaki, S.; Kitahara, H.; Ohara, T.; Kato, K.; Kawashiri, S.; Yamamoto, E. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Oncol. Rep. 2007, 18 (4), 987-991.
-
(2007)
Oncol. Rep
, vol.18
, Issue.4
, pp. 987-991
-
-
Yoshizawa, K.1
Nozaki, S.2
Kitahara, H.3
Ohara, T.4
Kato, K.5
Kawashiri, S.6
Yamamoto, E.7
-
63
-
-
0034162887
-
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance
-
Komatsu, M.; Sumizawa, T.; Mutoh, M.; Chen, Z. S.; Terada, K.; Furukawa, T.; Yang, X. L.; Gao, H.; Miura, N.; Sugiyama, T.; Akiyama, S. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 2000, 60 (5), 1312-1316.
-
(2000)
Cancer Res
, vol.60
, Issue.5
, pp. 1312-1316
-
-
Komatsu, M.1
Sumizawa, T.2
Mutoh, M.3
Chen, Z.S.4
Terada, K.5
Furukawa, T.6
Yang, X.L.7
Gao, H.8
Miura, N.9
Sugiyama, T.10
Akiyama, S.11
-
64
-
-
0028279046
-
Active efflux system for cisplatin in cisplatin-resistant human KB cells
-
Fujii, R.; Mutoh, M.; Niwa, K.; Yamada, K.; Aikou, T.; Nakagawa, M.; Kuwano, M.; Akiyama, S. Active efflux system for cisplatin in cisplatin-resistant human KB cells. Jpn. J. Cancer Res. 1994, 85 (4), 426-433.
-
(1994)
Jpn. J. Cancer Res
, vol.85
, Issue.4
, pp. 426-433
-
-
Fujii, R.1
Mutoh, M.2
Niwa, K.3
Yamada, K.4
Aikou, T.5
Nakagawa, M.6
Kuwano, M.7
Akiyama, S.8
-
65
-
-
1442335459
-
Cross-resistance to cisplatin in cells with acquired resistance to copper
-
Safaei, R.; Katano, K.; Samimi, G.; Naerdemann, W.; Stevenson, J. L.; Rochdi, M.; Howell, S. B. Cross-resistance to cisplatin in cells with acquired resistance to copper. Cancer Chemother. Pharmacol. 2004, 53 (3), 239-246.
-
(2004)
Cancer Chemother. Pharmacol
, vol.53
, Issue.3
, pp. 239-246
-
-
Safaei, R.1
Katano, K.2
Samimi, G.3
Naerdemann, W.4
Stevenson, J.L.5
Rochdi, M.6
Howell, S.B.7
-
66
-
-
10644269449
-
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs
-
Safaei, R.; Howell, S. B. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit. Rev. Oncol. Hematol. 2005, 53 (1), 13-23.
-
(2005)
Crit. Rev. Oncol. Hematol
, vol.53
, Issue.1
, pp. 13-23
-
-
Safaei, R.1
Howell, S.B.2
-
67
-
-
0041341920
-
The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells
-
Katano, K.; Safaei, R.; Samimi, G.; Holzer, A.; Rochdi, M.; Howell, S. B. The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol. Pharmacol. 2003, 64 (2), 466-473.
-
(2003)
Mol. Pharmacol
, vol.64
, Issue.2
, pp. 466-473
-
-
Katano, K.1
Safaei, R.2
Samimi, G.3
Holzer, A.4
Rochdi, M.5
Howell, S.B.6
-
68
-
-
0035515217
-
Expression and cisplatin sensitivity of coppertransporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines
-
Nakayama, K.; Miyazaki, K.; Kanzaki, A.; Fukumoto, M.; Takebayashi, Y. Expression and cisplatin sensitivity of coppertransporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines. Oncol. Rep. 2001, 8 (6), 1285-1287.
-
(2001)
Oncol. Rep
, vol.8
, Issue.6
, pp. 1285-1287
-
-
Nakayama, K.1
Miyazaki, K.2
Kanzaki, A.3
Fukumoto, M.4
Takebayashi, Y.5
-
69
-
-
65649088246
-
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy
-
Martinez-Balibrea, E.; Martinez-Cardus, A.; Musulen, E.; Gines, A.; Manzano, J. L.; Aranda, E.; Plasencia, C.; Neamati, N.; Abad, A.; Martinez-Balibrea, E.; Martinez-Cardus, A.; Musulen, E.; Gines, A.; Manzano, J. L.; Aranda, E.; Plasencia, C.; Neamati, N.; Abad, A. Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy. Int. J. Cancer 2009, 124 (12), 2905-2910.
-
(2009)
Int. J. Cancer
, vol.124
, Issue.12
, pp. 2905-2910
-
-
Martinez-Balibrea, E.1
Martinez-Cardus, A.2
Musulen, E.3
Gines, A.4
Manzano, J.L.5
Aranda, E.6
Plasencia, C.7
Neamati, N.8
Abad, A.9
Martinez-Balibrea, E.10
Martinez-Cardus, A.11
Musulen, E.12
Gines, A.13
Manzano, J.L.14
Aranda, E.15
Plasencia, C.16
Neamati, N.17
Abad, A.18
-
70
-
-
0347447284
-
Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients.[see comment]
-
Samimi, G.; Varki, N. M.; Wilczynski, S.; Safaei, R.; Alberts, D. S.; Howell, S. B. Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients.[see comment]. Clin. Cancer Res. 2003, 9 (16 Pt 1), 5853-5859.
-
(2003)
Clin. Cancer Res
, vol.9
, Issue.16 Pt 1
, pp. 5853-5859
-
-
Samimi, G.1
Varki, N.M.2
Wilczynski, S.3
Safaei, R.4
Alberts, D.S.5
Howell, S.B.6
-
71
-
-
0037112421
-
Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper
-
Katano, K.; Kondo, A.; Safaei, R.; Holzer, A.; Samimi, G.; Mishima, M.; Kuo, Y.-M.; Rochdi, M.; Howell, S. B. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res. 2002, 62 (22), 6559-6565.
-
(2002)
Cancer Res
, vol.62
, Issue.22
, pp. 6559-6565
-
-
Katano, K.1
Kondo, A.2
Safaei, R.3
Holzer, A.4
Samimi, G.5
Mishima, M.6
Kuo, Y.-M.7
Rochdi, M.8
Howell, S.B.9
-
72
-
-
0027475976
-
Isolation of a partial candidate gene for Menkes disease by positional cloning
-
Mercer, J. F.; Livingston, J.; Hall, B.; Paynter, J. A.; Begy, C.; Chandrasekharappa, S.; Lockhart, P.; Grimes, A.; Bhave, M.; Siemieniak, D.; Glover, T. W. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 1993, 3 (1), 20-25.
-
(1993)
Nat. Genet
, vol.3
, Issue.1
, pp. 20-25
-
-
Mercer, J.F.1
Livingston, J.2
Hall, B.3
Paynter, J.A.4
Begy, C.5
Chandrasekharappa, S.6
Lockhart, P.7
Grimes, A.8
Bhave, M.9
Siemieniak, D.10
Glover, T.W.11
-
73
-
-
0034635468
-
The ATP hydrolytic activity of purified ZntA, a Pb(II)/Cd(II)/Zn(II)- translocating ATPase from Escherichia coli
-
Sharma, R.; Rensing, C.; Rosen, B. P.; Mitra, B. The ATP hydrolytic activity of purified ZntA, a Pb(II)/Cd(II)/Zn(II)- translocating ATPase from Escherichia coli. J. Biol. Chem. 2000, 275 (6), 3873-3878.
-
(2000)
J. Biol. Chem
, vol.275
, Issue.6
, pp. 3873-3878
-
-
Sharma, R.1
Rensing, C.2
Rosen, B.P.3
Mitra, B.4
-
74
-
-
0028972922
-
Gene amplification of the Menkes (MNK; ATP7A) P-type ATPase gene of CHO cells is associated with copper resistance and enhanced copper efflux
-
Camakaris, J.; Petris, M. J.; Bailey, L.; Shen, P.; Lockhart, P.; Glover, T. W.; Barcroft, C.; Patton, J.; Mercer, J. F. Gene amplification of the Menkes (MNK; ATP7A) P-type ATPase gene of CHO cells is associated with copper resistance and enhanced copper efflux. Hum. Mol. Genet. 1995, 4 (11), 2117-2123.
-
(1995)
Hum. Mol. Genet
, vol.4
, Issue.11
, pp. 2117-2123
-
-
Camakaris, J.1
Petris, M.J.2
Bailey, L.3
Shen, P.4
Lockhart, P.5
Glover, T.W.6
Barcroft, C.7
Patton, J.8
Mercer, J.F.9
-
75
-
-
0034474183
-
The molecular basis of copper-transport diseases
-
Mercer, J. F. The molecular basis of copper-transport diseases. Trends Mol. Med. 2001, 7 (2), 64-69.
-
(2001)
Trends Mol. Med
, vol.7
, Issue.2
, pp. 64-69
-
-
Mercer, J.F.1
-
76
-
-
34250306256
-
Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer
-
Owatari, S.; Akune, S.; Komatsu, M.; Ikeda, R.; Firth, S. D.; Che, X.-F.; Yamamoto, M.; Tsujikawa, K.; Kitazono, M.; Ishizawa, T.; Takeuchi, T.; Aikou, T.; Mercer, J. F. B.; Akiyama, S.-I.; Furukawa, T. Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer. Cancer Res. 2007, 67 (10), 4860-4868.
-
(2007)
Cancer Res
, vol.67
, Issue.10
, pp. 4860-4868
-
-
Owatari, S.1
Akune, S.2
Komatsu, M.3
Ikeda, R.4
Firth, S.D.5
Che, X.-F.6
Yamamoto, M.7
Tsujikawa, K.8
Kitazono, M.9
Ishizawa, T.10
Takeuchi, T.11
Aikou, T.12
Mercer, J.F.B.13
Akiyama, S.-I.14
Furukawa, T.15
-
77
-
-
33645751935
-
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters
-
Samimi, G.; Howell, S. B. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters. Cancer Chemother. Pharmacol. 2006, 57 (6), 781-788.
-
(2006)
Cancer Chemother. Pharmacol
, vol.57
, Issue.6
, pp. 781-788
-
-
Samimi, G.1
Howell, S.B.2
-
78
-
-
5444256896
-
The role of copper transporters in the development of resistance to Pt drugs
-
Safaei, R.; Holzer, A. K.; Katano, K.; Samimi, G.; Howell, S. B. The role of copper transporters in the development of resistance to Pt drugs. J. Inorg. Biochem. 2004, 98 (10), 1607-1613.
-
(2004)
J. Inorg. Biochem
, vol.98
, Issue.10
, pp. 1607-1613
-
-
Safaei, R.1
Holzer, A.K.2
Katano, K.3
Samimi, G.4
Howell, S.B.5
-
79
-
-
3242734736
-
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells
-
Samimi, G.; Safaei, R.; Katano, K.; Holzer, A. K.; Rochdi, M.; Tomioka, M.; Goodman, M.; Howell, S. B. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin. Cancer Res. 2004, 10 (14), 4661-4669.
-
(2004)
Clin. Cancer Res
, vol.10
, Issue.14
, pp. 4661-4669
-
-
Samimi, G.1
Safaei, R.2
Katano, K.3
Holzer, A.K.4
Rochdi, M.5
Tomioka, M.6
Goodman, M.7
Howell, S.B.8
-
80
-
-
33646130414
-
Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: Comprehensive profiles by representational difference analysis, microarrays and proteomics
-
Nagaraja, G. M.; Othman, M.; Fox, B. P.; Alsaber, R.; Pellegrino, C. M.; Zeng, Y.; Khanna, R.; Tamburini, P.; Swaroop, A.; Kandpal, R. P. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 2006, 25 (16), 2328-2338.
-
(2006)
Oncogene
, vol.25
, Issue.16
, pp. 2328-2338
-
-
Nagaraja, G.M.1
Othman, M.2
Fox, B.P.3
Alsaber, R.4
Pellegrino, C.M.5
Zeng, Y.6
Khanna, R.7
Tamburini, P.8
Swaroop, A.9
Kandpal, R.P.10
-
81
-
-
27744434713
-
Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma
-
Crnogorac-Jurcevic, T.; Gangeswaran, R.; Bhakta, V.; Capurso, G.; Lattimore, S.; Akada, M.; Sunamura, M.; Prime, W.; Campbell, F.; Brentnall, T. A.; Costello, E.; Neoptolemos, J.; Lemoine, N. R. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 2005, 129 (5), 1454-1463.
-
(2005)
Gastroenterology
, vol.129
, Issue.5
, pp. 1454-1463
-
-
Crnogorac-Jurcevic, T.1
Gangeswaran, R.2
Bhakta, V.3
Capurso, G.4
Lattimore, S.5
Akada, M.6
Sunamura, M.7
Prime, W.8
Campbell, F.9
Brentnall, T.A.10
Costello, E.11
Neoptolemos, J.12
Lemoine, N.R.13
-
82
-
-
0026494344
-
Microenvironment and angiogenic response
-
Gullino, P. M. Microenvironment and angiogenic response. EXS 1992, 61, 125-128.
-
(1992)
EXS
, vol.61
, pp. 125-128
-
-
Gullino, P.M.1
-
83
-
-
0032104855
-
Copper stimulates proliferation of human endothelial cells under culture
-
Hu, G. F. Copper stimulates proliferation of human endothelial cells under culture. J. Cell Biochem. 1998, 69 (3), 326-335.
-
(1998)
J. Cell Biochem
, vol.69
, Issue.3
, pp. 326-335
-
-
Hu, G.F.1
-
84
-
-
0027448830
-
Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors
-
Yoshida, D.; Ikeda, Y.; Nakazawa, S. Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors. J. Neurooncol. 1993, 16 (2), 109-115.
-
(1993)
J. Neurooncol
, vol.16
, Issue.2
, pp. 109-115
-
-
Yoshida, D.1
Ikeda, Y.2
Nakazawa, S.3
-
85
-
-
0023860218
-
Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea
-
Parke, A.; Bhattacherjee, P.; Palmer, R. M.; Lazarus, N. R. Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea. Am. J. Pathol. 1988, 130 (1), 173-178.
-
(1988)
Am. J. Pathol
, vol.130
, Issue.1
, pp. 173-178
-
-
Parke, A.1
Bhattacherjee, P.2
Palmer, R.M.3
Lazarus, N.R.4
-
86
-
-
0020000982
-
Role of prostaglandin E1 and copper in angiogenesis
-
Ziche, M.; Jones, J.; Gullino, P. M. Role of prostaglandin E1 and copper in angiogenesis. J. Natl. Cancer Inst. 1982, 69 (2), 475-482.
-
(1982)
J. Natl. Cancer Inst
, vol.69
, Issue.2
, pp. 475-482
-
-
Ziche, M.1
Jones, J.2
Gullino, P.M.3
-
87
-
-
0025202925
-
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor
-
Brem, S. S.; Zagzag, D.; Tsanaclis, A. M.; Gately, S.; Elkouby, M. P.; Brien, S. E. Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am. J. Pathol. 1990, 137 (5), 1121-1142.
-
(1990)
Am. J. Pathol
, vol.137
, Issue.5
, pp. 1121-1142
-
-
Brem, S.S.1
Zagzag, D.2
Tsanaclis, A.M.3
Gately, S.4
Elkouby, M.P.5
Brien, S.E.6
-
88
-
-
0025326091
-
Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain
-
Brem, S.; Tsanaclis, A. M.; Zagzag, D. Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain. Neurosurgery 1990, 26 (3), 391-396.
-
(1990)
Neurosurgery
, vol.26
, Issue.3
, pp. 391-396
-
-
Brem, S.1
Tsanaclis, A.M.2
Zagzag, D.3
-
89
-
-
78651068532
-
The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: Implications for chemotherapeutic action against cancer
-
Ullah, M. F.; Khan, H. Y.; Zubair, H.; Shamim, U.; Hadi, S. M. The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer. Cancer Chemother. Pharmacol. 2011, 67 (1), 103-110.
-
(2011)
Cancer Chemother. Pharmacol
, vol.67
, Issue.1
, pp. 103-110
-
-
Ullah, M.F.1
Khan, H.Y.2
Zubair, H.3
Shamim, U.4
Hadi, S.M.5
-
90
-
-
0037337399
-
Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy
-
Brewer, G. J.; Hedera, P.; Kluin, K. J.; Carlson, M.; Askari, F.; Dick, R. B.; Sitterly, J.; Fink, J. K. Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch. Neurol. 2003, 60 (3), 379-385.
-
(2003)
Arch. Neurol
, vol.60
, Issue.3
, pp. 379-385
-
-
Brewer, G.J.1
Hedera, P.2
Kluin, K.J.3
Carlson, M.4
Askari, F.5
Dick, R.B.6
Sitterly, J.7
Fink, J.K.8
-
91
-
-
0035073521
-
The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma
-
Cox, C.; Teknos, T. N.; Barrios, M.; Brewer, G. J.; Dick, R. D.; Merajver, S. D. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope 2001, 111 (4 Pt 1), 696-701.
-
(2001)
Laryngoscope
, vol.111
, Issue.4 Pt 1
, pp. 696-701
-
-
Cox, C.1
Teknos, T.N.2
Barrios, M.3
Brewer, G.J.4
Dick, R.D.5
Merajver, S.D.6
-
92
-
-
34147146006
-
Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer
-
Hassouneh, B.; Islam, M.; Nagel, T.; Pan, Q.; Merajver, S. D.; Teknos, T. N.; Hassouneh, B.; Islam, M.; Nagel, T.; Pan, Q.; Merajver, S. D.; Teknos, T. N. Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer. Mol. Cancer Ther. 2007, 6 (3), 1039-1045.
-
(2007)
Mol. Cancer Ther
, vol.6
, Issue.3
, pp. 1039-1045
-
-
Hassouneh, B.1
Islam, M.2
Nagel, T.3
Pan, Q.4
Merajver, S.D.5
Teknos, T.N.6
Hassouneh, B.7
Islam, M.8
Nagel, T.9
Pan, Q.10
Merajver, S.D.11
Teknos, T.N.12
-
93
-
-
77955098807
-
Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis
-
Kumar, P.; Yadav, A.; Patel, S. N.; Islam, M.; Pan, Q.; Merajver, S. D.; Teknos, T. N.; Kumar, P.; Yadav, A.; Patel, S. N.; Islam, M.; Pan, Q.; Merajver, S. D.; Teknos, T. N. Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis. Mol. Cancer 2010, 9, 206.
-
(2010)
Mol. Cancer
, vol.9
, pp. 206
-
-
Kumar, P.1
Yadav, A.2
Patel, S.N.3
Islam, M.4
Pan, Q.5
Merajver, S.D.6
Teknos, T.N.7
Kumar, P.8
Yadav, A.9
Patel, S.N.10
Islam, M.11
Pan, Q.12
Merajver, S.D.13
Teknos, T.N.14
-
94
-
-
0033963879
-
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study
-
Brewer, G. J.; Dick, R. D.; Grover, D. K.; LeClaire, V.; Tseng, M.; Wicha, M.; Pienta, K.; Redman, B. G.; Jahan, T.; Sondak, V. K.; Strawderman, M.; LeCarpentier, G.; Merajver, S. D. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin. Cancer Res. 2000, 6 (1), 1-10.
-
(2000)
Clin. Cancer Res
, vol.6
, Issue.1
, pp. 1-10
-
-
Brewer, G.J.1
Dick, R.D.2
Grover, D.K.3
Leclaire, V.4
Tseng, M.5
Wicha, M.6
Pienta, K.7
Redman, B.G.8
Jahan, T.9
Sondak, V.K.10
Strawderman, M.11
Lecarpentier, G.12
Merajver, S.D.13
-
95
-
-
77953270903
-
Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator
-
Ishida, S.; McCormick, F.; Smith-McCune, K.; Hanahan, D. Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell. 2010, 17 (6), 574-583.
-
(2010)
Cancer Cell
, vol.17
, Issue.6
, pp. 574-583
-
-
Ishida, S.1
McCormick, F.2
Smith-McCune, K.3
Hanahan, D.4
-
96
-
-
0037652214
-
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer
-
Redman, B. G.; Esper, P.; Pan, Q.; Dunn, R. L.; Hussain, H. K.; Chenevert, T.; Brewer, G. J.; Merajver, S. D. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin. Cancer Res. 2003, 9 (5), 1666-1672.
-
(2003)
Clin. Cancer Res
, vol.9
, Issue.5
, pp. 1666-1672
-
-
Redman, B.G.1
Esper, P.2
Pan, Q.3
Dunn, R.L.4
Hussain, H.K.5
Chenevert, T.6
Brewer, G.J.7
Merajver, S.D.8
-
97
-
-
34548083741
-
Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer
-
Henry, N. L.; Dunn, R.; Merjaver, S.; Pan, Q.; Pienta, K. J.; Brewer, G.; Smith, D. C. Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer. Oncology 2006, 71 (3/4), 168-175.
-
(2006)
Oncology
, vol.71
, Issue.3-4
, pp. 168-175
-
-
Henry, N.L.1
Dunn, R.2
Merjaver, S.3
Pan, Q.4
Pienta, K.J.5
Brewer, G.6
Smith, D.C.7
-
98
-
-
47149104324
-
A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: Final results
-
discussion 390
-
Pass, H. I.; Brewer, G. J.; Dick, R.; Carbone, M.; Merajver, S. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results. Ann. Thorac. Surg. 2008, 86 (2), 383-389; discussion 390.
-
(2008)
Ann. Thorac. Surg
, vol.86
, Issue.2
, pp. 383-389
-
-
Pass, H.I.1
Brewer, G.J.2
Dick, R.3
Carbone, M.4
Merajver, S.5
-
99
-
-
0042830827
-
Prolonged copper depletion induces expression of antioxidants and triggers apoptosis in SH-SY5Y neuroblastoma cells
-
Lombardo, M. F.; Ciriolo, M. R.; Rotilio, G.; Rossi, L. Prolonged copper depletion induces expression of antioxidants and triggers apoptosis in SH-SY5Y neuroblastoma cells. Cell Mol. Life Sci. 2003, 60 (8), 1733-1743.
-
(2003)
Cell Mol. Life Sci
, vol.60
, Issue.8
, pp. 1733-1743
-
-
Lombardo, M.F.1
Ciriolo, M.R.2
Rotilio, G.3
Rossi, L.4
|